DASH vs SER
DoorDash, Inc. Class A Common Stock (DASH) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. SER currently screens at market cap $29.7M.
Not investment advice. Open the DASH and SER stock pages for the full models.
Not investment advice.